Fibroblast growth factor-1 improves cardiac functional recovery and enhances cell survival after ischemia and reperfusion: a fibroblast growth factor receptor, protein kinase C, and tyrosine kinase-dependent mechanism
- PMID: 15337227
- DOI: 10.1016/j.jacc.2004.05.067
Fibroblast growth factor-1 improves cardiac functional recovery and enhances cell survival after ischemia and reperfusion: a fibroblast growth factor receptor, protein kinase C, and tyrosine kinase-dependent mechanism
Abstract
Objectives: We sought to investigate the role of fibroblast growth factor (FGF)-1 during acute myocardial ischemia and reperfusion.
Background: The FGFs display cardioprotective effects during ischemia and reperfusion.
Methods: We investigated FGF-1-induced cardioprotection during ischemia and reperfusion and the intracellular signaling pathways responsible for these effects in an ex vivo murine setup of myocardial ischemia and reperfusion.
Results: Cardiac-specific human FGF-1 overexpression was associated with enhanced post-ischemic hemodynamic recovery and decreased lactate dehydrogenase release during reperfusion. Inhibition of the FGF receptor, protein kinase C (PKC), and tyrosine kinase (TK) resulted in blockade of FGF-1-induced protective effects on cardiac functional recovery and cell death.
Conclusions: The overexpression of FGF-1 induces cardioprotection through a pathway that involves the FGF receptor, PKC, and TK.
Similar articles
-
FGF-2-induced negative inotropism and cardioprotection are inhibited by chelerythrine: involvement of sarcolemmal calcium-independent protein kinase C.J Mol Cell Cardiol. 1998 Dec;30(12):2695-709. doi: 10.1006/jmcc.1998.0832. J Mol Cell Cardiol. 1998. PMID: 9990540
-
Cardiac-specific overexpression of fibroblast growth factor-2 protects against myocardial dysfunction and infarction in a murine model of low-flow ischemia.Circulation. 2003 Dec 23;108(25):3140-8. doi: 10.1161/01.CIR.0000105723.91637.1C. Epub 2003 Dec 1. Circulation. 2003. PMID: 14656920
-
Inhibition of protein kinase C alpha improves myocardial beta-adrenergic receptor signaling and ventricular function in a model of myocardial preservation.J Thorac Cardiovasc Surg. 2008 Jan;135(1):172-9, 179.e1. doi: 10.1016/j.jtcvs.2007.08.035. J Thorac Cardiovasc Surg. 2008. PMID: 18179937
-
Molecular mechanisms of angiogenesis: experimental models define cellular trafficking of FGF-1.P R Health Sci J. 1996 Sep;15(3):179-86. P R Health Sci J. 1996. PMID: 8994282 Review.
-
Cellular signaling by fibroblast growth factor receptors.Cytokine Growth Factor Rev. 2005 Apr;16(2):139-49. doi: 10.1016/j.cytogfr.2005.01.001. Epub 2005 Feb 1. Cytokine Growth Factor Rev. 2005. PMID: 15863030 Review.
Cited by
-
Exosomes: Their Role in Pathogenesis, Diagnosis and Treatment of Diseases.Cancers (Basel). 2020 Dec 30;13(1):84. doi: 10.3390/cancers13010084. Cancers (Basel). 2020. PMID: 33396739 Free PMC article. Review.
-
Fibroblast growth factor-2 and cardioprotection.Heart Fail Rev. 2007 Dec;12(3-4):267-77. doi: 10.1007/s10741-007-9027-0. Heart Fail Rev. 2007. PMID: 17516168 Review.
-
Reverse Cardio-Oncology: Cancer Development in Patients With Cardiovascular Disease.J Am Heart Assoc. 2020 Jan 21;9(2):e013754. doi: 10.1161/JAHA.119.013754. Epub 2020 Jan 21. J Am Heart Assoc. 2020. PMID: 31960736 Free PMC article. Review. No abstract available.
-
Fibroblast Growth Factor 1-Transfected Adipose-Derived Mesenchymal Stem Cells Promote Angiogenic Proliferation.DNA Cell Biol. 2017 May;36(5):401-412. doi: 10.1089/dna.2016.3546. Epub 2017 Mar 10. DNA Cell Biol. 2017. PMID: 28281780 Free PMC article.
-
Two promising approaches in the treatment of myocardial infarction: stem cells and gene therapy.Front Cardiovasc Med. 2025 Feb 19;12:1540066. doi: 10.3389/fcvm.2025.1540066. eCollection 2025. Front Cardiovasc Med. 2025. PMID: 40046966 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources